Skip to main content

Bahrain authorizes China’s Sinopharm vaccine for children

Authorities around the world are divided on the necessity of vaccinating children against COVID-19.
Bahrain vaccine

Bahrain announced today that children will soon be eligible to receive doses of Sinopharm vaccine against COVID-19. 

Children ages three to 11 can begin receiving the Chinese vaccine starting tomorrow. The decision follows an approval from the coronavirus task force in the Ministry of Health. The taskforce is urging children to receive the vaccine to “protect themselves, their families, and public health,” the official Bahrain News Agency reported

COVID-19 cases are at a historic low in Bahrain. The country of around 1.7 million is averaging only 65 cases a day at present, according to data from Reuters. More than 65% of the population is fully vaccinated against the coronavirus, according to the Oxford-based Our World in Data. 

Bahrain is not the first country in the Gulf to approve Sinopharm for children. In August, the United Arab Emirates approved the vaccine for kids aged three to 17.

The World Health Organization currently does not advocate for vaccinating most children, in part because of their lesser risk of getting seriously sick. 

“Children and adolescents tend to have milder disease compared to adults, so unless they are part of a group at higher risk of severe COVID-19, it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers,” read the WHO’s most recent update on the subject in July. “More evidence is needed on the use of the different COVID-19 vaccines in children to be able to make general recommendations on vaccinating children against COVID-19.”

There have been protests against COVID-19 vaccines for children in some areas around the world where it is required. The subject also spurred a political debate in Israel in August. 

There also concerns about Sinopharm’s utility in general, including in Bahrain and the UAE. In June, a 48-year-old political prisoner in Bahrain died of COVID-19, despite being fully vaccinated with Sinopharm. The same month, Bahrain authorized booster shots of the Pfizer-BioNTech vaccine for people originally inoculated with Sinopharm amid rising virus cases. In August, the UAE capital Abu Dhabi made booster shots mandatory for those who received Sinopharm. They did not institute this policy for recipients of other vaccines. 

Sinopharm is also not recognized as a valid vaccine in many parts of the world. The vaccine does not have approval from the European Union, for example.

Bahraini authorities will also approve the Pfizer-BioNTech vaccine for five-to-11-year-olds “soon,” according to the Bahrain News Agency. 

Join hundreds of Middle East professionals with Al-Monitor PRO.

Business and policy professionals use PRO to monitor the regional economy and improve their reports, memos and presentations. Try it for free and cancel anytime.

Already a Member? Sign in


The Middle East's Best Newsletters

Join over 50,000 readers who access our journalists dedicated newsletters, covering the top political, security, business and tech issues across the region each week.
Delivered straight to your inbox.


What's included:
Our Expertise

Free newsletters available:

  • The Takeaway & Week in Review
  • Middle East Minute (AM)
  • Daily Briefing (PM)
  • Business & Tech Briefing
  • Security Briefing
  • Gulf Briefing
  • Israel Briefing
  • Palestine Briefing
  • Turkey Briefing
  • Iraq Briefing

Premium Membership

Join the Middle East's most notable experts for premium memos, trend reports, live video Q&A, and intimate in-person events, each detailing exclusive insights on business and geopolitical trends shaping the region.

$25.00 / month
billed annually

Become Member Start with 1-week free trial
What's included:
Our Expertise AI-driven

Memos - premium analytical writing: actionable insights on markets and geopolitics.

Live Video Q&A - Hear from our top journalists and regional experts.

Special Events - Intimate in-person events with business & political VIPs.

Trend Reports - Deep dive analysis on market updates.

All premium Industry Newsletters - Monitor the Middle East's most important industries. Prioritize your target industries for weekly review:

  • Capital Markets & Private Equity
  • Venture Capital & Startups
  • Green Energy
  • Supply Chain
  • Sustainable Development
  • Leading Edge Technology
  • Oil & Gas
  • Real Estate & Construction
  • Banking

We also offer team plans. Please send an email to and we'll onboard your team.

Already a Member? Sign in

Start your PRO membership today.

Join the Middle East's top business and policy professionals to access exclusive PRO insights today.

Join Al-Monitor PRO Start with 1-week free trial